Managing swallowing and communication in progressive neurological diseases
Instructor led
Added:25/03/2024 16:03

2x 3hr weekly sessions starting 15 July 2024
Credits awarded per Session. See individual Sessions for further details.
Credits awarded
Sub type
Certificate awarded
Already successfully completed: re-enrollment available!

About this item

2x 3hr weekly sessions starting 15 July 2024

Course/Activity Information

Session 1: Monday 15 July 2024, 1:30pm - 4:30pm (AEST) 

Session 2: Monday 22 July 2024, 1:30pm - 4:30pm (AEST) 

This workshop will provide an overview of progressive neurological disorders (PND), exploring communication and swallowing presentations and evidence-based interventions. Interactive activities will be used to exchange ideas, learn from peers and apply evidence and clinical reasoning to various clinical scenarios.

Learning objectives

Upon successful completion of this workshop, participants will be able to:

  • describe the key clinical features and phenotypes of PNDs, including Parkinson’s Disease (PD), Motor Neuron Disease (MND), Huntington’s Disease (HD), Friedreich's Ataxia (FA), Multiple Sclerosis (MS)
  • explain additional factors in PND impacting assessment and management of communication and swallowing
  • evaluate the risks and benefits of impairment-based therapy for dysarthria and dysphonia in PND
  • outline specific considerations for communication and swallowing management in the context of life-limiting Illness in PND
  • navigate the clinical reasoning around alternative nutrition and eating and drinking with acknowledged risk, within frameworks of clinical guidelines and ethico-legal implications
  • implement an AAC solution matching a person's cognitive, linguistic, physical and psychological needs
  • discuss the responsibilities, breadth / scope of the SP role in the MDT working with people with PND
  • outline issues to consider when educating people with PND and their carers about communication and swallowing
  • explain the multi-dimensional therapeutic framework that guides SP interventions with PND
  • apply theory and evidence to daily clinical assessment and management
  • develop a tool kit of resources to use in clinical practice.


Dr Anna Farrell

Dr Anna Farrell is the Director of Speech Pathology at Princess Alexandra Hospital, Metro South Health. Anna has extensive clinical experience in adult neurological disorders in Australia and the United Kingdom. Anna completed doctoral research evaluating the impact of neurosurgical treatments on motor speech function in Parkinson’s disease at The University of Queensland.

Dr Shana Taubert

Dr Shana Taubert is a speech pathologist at The Royal Brisbane and Women’s Hospital, where her clinical caseload is predominantly Neurology inpatient and outpatients, the majority of whom have progressive neurological disorders. Shana completed her PhD at the University of Queensland, investigating Enhancement of speech pathology provision of videofluoroscopic swallow studies.


  • Members: $231
  • Non-practicing members: $152
  • Student Members: $116
  • Non-Members: $347